Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Observational, Multi-Center, Real-World Study of Toripalimab Injection in First-Line Treatment of Extensive-Stage Small Cell Lung Cancer

NCT07308379 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT07308379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07308379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Observational, Multi-Center, Real-World Study of Toripalimab Injection in First-Line Treatment of Extensive-Stage Small Cell Lung Cancer
Lead sponsor
Fudan University
Phase
Observational
Overall status
Not yet recruiting
Start date
February 28, 2026
Completion date
August 31, 2028
Enrollment
1,200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

sclc, extensive stage, toripalimab